tiprankstipranks
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market
1672
Ascletis Pharma, Inc.
RESEARCH TOOLSreports
Want to see HK:1672 full AI Analyst Report?

Ascletis Pharma, Inc. (1672) Ratios

9 Followers

Ascletis Pharma, Inc. Ratios

HK:1672's free cash flow for Q4 2025 was ¥-8.21. For the 2025 fiscal year, HK:1672's free cash flow was decreased by ¥ and operating cash flow was ¥-310.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 15.05 15.05 12.88 16.58 23.52
Quick Ratio
 15.04 15.04 12.85 16.54 23.33
Cash Ratio
 11.31 11.31 5.66 2.35 22.84
Solvency Ratio
 -2.62 -2.57 -1.81 -0.85 -2.43
Operating Cash Flow Ratio
 -2.97 -2.58 -2.23 -1.02 -1.32
Short-Term Operating Cash Flow Coverage
 -131.99 -114.62 0.00 0.00 0.00
Net Current Asset Value
¥ 1.79B¥ 1.79B¥ 1.81B¥ 2.18B¥ 2.43B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.07 1.07 1.08 1.06 1.05
Debt Service Coverage Ratio
 -157.40 -149.60 0.00 -875.63 -2.14K
Interest Coverage Ratio
 -6.32K -2.95K 0.00 -2.08K -2.19K
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 3.10 3.17 2.20 2.55 8.67
Profitability Margins
Gross Profit Margin
-373.74%-842.70%57.29%45.92%-45.65%
EBIT Margin
-23815.93%-23853.96%-31538.04%-255.44%-581.78%
EBITDA Margin
-23084.17%-22985.27%-30432.58%-222.79%-525.97%
Operating Profit Margin
-23797.69%-23853.96%-23025.64%-530.44%-635.94%
Pretax Profit Margin
-17634.72%-17720.62%-23455.65%-255.70%-582.07%
Net Profit Margin
-17659.45%-17745.57%-23455.65%-255.70%-582.07%
Continuous Operations Profit Margin
-17609.99%-17695.67%-23455.65%-255.70%-582.07%
Net Income Per EBT
100.14%100.14%100.00%100.00%100.00%
EBT Per EBIT
74.10%74.29%101.87%48.20%91.53%
Return on Assets (ROA)
-17.19%-16.96%-14.16%-5.81%-11.85%
Return on Equity (ROE)
-18.69%-18.12%-15.31%-6.18%-12.40%
Return on Capital Employed (ROCE)
-24.69%-24.29%-14.98%-12.77%-13.50%
Return on Invested Capital (ROIC)
-24.62%-24.22%-14.94%-12.74%-13.48%
Return on Tangible Assets
-17.27%-17.04%-14.25%-5.87%-11.92%
Earnings Yield
-2.50%-3.52%-10.63%-11.44%-6.92%
Efficiency Ratios
Receivables Turnover
 0.15 0.15 8.44 10.42 2.27
Payables Turnover
 7.09 13.85 17.68 47.16 25.13
Inventory Turnover
 5.08 9.93 0.13 5.04 3.84
Fixed Asset Turnover
 0.04 0.04 0.02 0.83 0.74
Asset Turnover
 <0.01 <0.01 <0.01 0.02 0.02
Working Capital Turnover Ratio
 <0.01 <0.01 <0.01 0.02 0.02
Cash Conversion Cycle
 2.42K 2.45K 2.94K 99.69 241.64
Days of Sales Outstanding
 2.40K 2.44K 43.24 35.03 161.10
Days of Inventory Outstanding
 71.79 36.74 2.91K 72.40 95.07
Days of Payables Outstanding
 51.48 26.35 20.65 7.74 14.52
Operating Cycle
 2.47K 2.48K 2.96K 107.43 256.16
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.39 -0.34 -0.34 -0.13 -0.13
Free Cash Flow Per Share
 -0.39 -0.34 -0.34 -0.15 -0.14
CapEx Per Share
 <0.01 <0.01 <0.01 0.02 0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.01 1.13 1.10
Dividend Paid and CapEx Coverage Ratio
 -660.94 -205.70 -159.02 -7.52 -9.89
Capital Expenditure Coverage Ratio
 -660.94 -205.70 -159.02 -7.52 -9.89
Operating Cash Flow Coverage Ratio
 -73.47 -63.80 -44.75 -17.13 -33.62
Operating Cash Flow to Sales Ratio
 -188.41 -166.65 -266.23 -2.55 -2.63
Free Cash Flow Yield
-2.47%-3.33%-12.14%-12.91%-3.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -40.44 -28.38 -9.41 -8.74 -14.45
Price-to-Sales (P/S) Ratio
 7.72K 5.04K 2.21K 22.36 84.11
Price-to-Book (P/B) Ratio
 7.43 5.14 1.44 0.54 1.79
Price-to-Free Cash Flow (P/FCF) Ratio
 -40.93 -30.07 -8.24 -7.75 -29.01
Price-to-Operating Cash Flow Ratio
 -37.90 -30.22 -8.29 -8.78 -31.94
Price-to-Earnings Growth (PEG) Ratio
 1.17 -1.42 -0.07 0.16 -0.24
Price-to-Fair Value
 7.43 5.14 1.44 0.54 1.79
Enterprise Value Multiple
 -30.36 -18.74 -5.05 -7.48 -7.32
Enterprise Value
 13.94B 8.51B 1.97B 943.53M 2.08B
EV to EBITDA
 -30.00 -18.74 -5.05 -7.48 -7.32
EV to Sales
 6.93K 4.31K 1.54K 16.67 38.51
EV to Free Cash Flow
 -36.70 -25.72 -5.74 -5.78 -13.28
EV to Operating Cash Flow
 -36.76 -25.85 -5.78 -6.54 -14.62
Tangible Book Value Per Share
 1.98 1.98 1.95 2.16 2.32
Shareholders’ Equity Per Share
 1.98 1.99 1.96 2.18 2.34
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 0.00 0.00 -0.16
Revenue Per Share
 <0.01 <0.01 <0.01 0.05 0.05
Net Income Per Share
 -0.36 -0.36 -0.30 -0.13 -0.29
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.74 0.74 0.74 1.00 1.00
Research & Development to Revenue
 198.43 196.26 235.69 3.83 4.94
SG&A to Revenue
 35.81 33.85 79.30 1.11 0.29
Stock-Based Compensation to Revenue
 1.91 0.00 2.34 0.02 0.06
Income Quality
 1.07 0.94 1.14 1.00 0.45
Currency in CNY